15th KUMAMOTO AIDS Seminar
[Program] 
 Poster Session

  Organizers: Shinya Suzu & Yorifumi Satou

 
  Poster Session I  
  October 2nd, Thursday 13:00-14:40 13:00-13:30  One-minute presentation
  13:30-14:40  Discussion for posters with one-minute presentation
  Poster Session II (with Lunch)   
  October 3rd, Friday 12:05-14:05

12:05-13:05  Lunch and Poster

  13:05-14:05  Discussion for posters with oral presentation

 The poster numbers highlighted in blue make one-minute presentation on October 2nd.
 The poster numbers highlighted in green make oral presentation on October 3rd.
Poster No.
Presenter
Title
P-01
Shinichiro Hattori
[Kumamoto Univ.]
The water extract of Piper sarmentosum Roxb. potently inhibits early stage of HIV-1 infection
P-02
Kouki Matsuda
[Kumamoto Univ.]
Inhibition of HIV-1 entry by a tricyclic coumarin GUT-70
P-03
Ryusho Kariya
[Kumamoto Univ.]
HAMLET and BAMLET induce cell death of Primary Effusion Lymphoma
P-04
Eriko Kudo
[Kumamoto Univ.]
HIV-1 latent infection induces IκB-α stabilization via HIV-1 restriction factor COMMD1.
P-05
O-3A-27
Michihiro Hashimoto
[Kumamoto Univ.]
Nef-induced activation of macrophages is mediated by TAK1 and macropinocytosis
P-06
Farzana Bhuyan
[Kumamoto Univ.]
M-Sec mediates the tunneling nanotube-promoting activity of HIV-1 in macrophages
P-07
O-3A-26
Hesham E. Nasser
[Kumamoto Univ.]
Phenotypic characterization of fibrocytes, the recently identified HIV-1 host cells
P-08
Ryota Koba
[Kumamoto Univ.]
Feline TRIM25 interferes with the late stage of feline leukemia virus replication
P-09
O-3B-36
Kazuaki Monde
[Kumamoto Univ.]
Intrinsic interference between human endogenous retrovirus and HIV-1.
P-10
Yoshika Egami
[Kumamoto Univ.]
Construction of neutralizing antibody fragment against V3 with a broad cross-reactivity

P-11
O-3A-24

Muntasir Alam
[Kumamoto Univ.]
Mutations in gp41 that confer resistance to fusion inhibitors enhance the neutralization sensitivity to antibodies against both gp41 and gp120
P-12
Yasuhiro Maruta
[Kumamoto Univ.]
Mechanism of post-attachment neutralization of single-chain variable fragment (scFv) from anti-V3 monoclonal antibody against HIV-1
P-13
O-3A-25
Kristel Ramirez
[Kumamoto Univ.]
Evaluation of complementarity and synergy of conventional anti-HIV-1 antibodies derived from a single individual
P-14
Kazuki Tanaka
[Kumamoto Univ.]
Potent neutralizing activity of small antibody fragments targeting CD4i (CD4-induced) epitope
P-15
Yu Irahara
[Tokyo Medical and Dental Univ.]
A new type of small CD4 mimic molecules targeting an HIV envelope protein gp120
P-16
Misato Kotani
[Tokyo Medical and Dental Univ.]
Structure-activity relationship studies of CD4 mimic molecules
P-17
O-3B-37
Shigeyoshi Harada
[NIID]
Genetic and Structure-Function Analyses of Human Immunodeficiency Virus Type 1 Escape from CD4 Mimic Small Compounds (CD4MCs)
P-18
Yuko Yamada
[Keio Univ. / Tokyo Medical and Dental Univ.]
A CD4 mimic as an HIV entry inhibitor: Pharmacokinetics
P-19
Xuechao Zhao
[Nankai Univ., China]
The role of human immunodeficiency virus envelope during mother-to-infant transmission
P-20
O-3B-29
Samatchaya Boonchawalit
[Kumamoto Univ. / NIID]
Impact of maraviroc (MVC)-resistant mutations in the C1 and C4 regions of gp120 on sensitivity to antibody-mediated neutralization
P-21
Yusuke Nakano
[Kyoto Univ.]
Influence of CCR5 forms on the interaction of HIV-1 envelop glycoprotein gp120
P-22
O-3-38
Masayuki Amano
[Kumamoto Univ.]
Identification of HIV-1 Capsid decomposers that promote significant Capsid protein degradation in vitro.
P-23
O-3B-30
Hironori Hayashi
[NCGM]
Dimerization of HIV-1 Protease Occurs through Two Steps, Which Relates to the Mechanism of Protease Dimerization Inhibition by Darunavir
P-24
O-3A-18
Takushi Nomura
[NIID]
Broadening of CD8+ T-cell targets precedes accumulation of proviral escape mutations in SIV controllers
P-25
O-3A-23
Keiko Sakai
[Kumamoto Univ.]
Investigation of the association of Gag-dependent replication capacities with clinical outcomes of HIV-1 infection.
P-26
Tomohiro Akahoshi
[Kumamoto Univ.]
Conflicting viral selection by HIV-1-specific CTLs
P-27
Nozomi Kuse
[Kumamoto Univ.]
Long-term control of HIV-1 by two cross-reactive HLA-B*51:01-restricted CTLs
P-28
O-3A-21
Takayuki Chikata
[Kumamoto Univ.]
The impact of amino-acid substitution at a position outside the peptide binding groove of HLA-C subtypes in HIV-1-specific T cell recognition
P-29
Xiaoming Sun
[Kumamoto Univ.]
Analysis of non-canonical Vδ-Vβ TCRs in HIV-1 specific CTLs
P-30
O-3A-22
Zhansong Lin
[Kumamoto Univ.]
The effect of co-expression of KIRs and their HLA ligands on HIV-1 control
P-31
Tran Van Giang
[Kumamoto Univ.]
Identification of HLA-associated HIV-1subtype A/E polymorphism in a Vietnamese cohort
P-32
O-3A-19
Hayato Murakoshi
[Kumamoto Univ.]
Effective control of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes
P-33
Mohammad Arif Rahman
[Kumamoto Univ.]
Effect of NNRTI-resistance Y181C/V/I mutations on HIV-1-specific CTL recognition in subtype B and the subtype A/E infections
P-34
Bin Liu
[Nankai Univ., China]
Subtypes, CTL epitope variation and silencing by a broad-spectrum short hairpin RNA of HIV-1 gag gene from epidemic strains among men who have sex with men (MSM) in Tianjin, China
P-35
Mako Toyoda
[Kumamoto Univ.]
Differential modulation of Nef-mediated down-regulation of viral entry receptors is mediated by multiple sequence motifs in HIV-1 elite controllers.
P-36
O-3A-20
Macdonald Mahiti
[Kumamoto Univ.]
Natural isolated HIV-1 Nef differentially recognize the cytoplasmic tails of HLA-A and HLA-B molecules for down-regulation
P-37
Stanley C. Meribe
[Kumamoto Univ.]
Functional characterization of a deleterious naturally-arising HIV-1 Nef polymorphism Ile-20
P-38
Doreen Kamori
[Kumamoto Univ.]
Effects of natural variability of an immunodominant Vpr region on immunological footprints and protein functions.
P-39
Francis Mwimanzi
[Kumamoto Univ.]
Establishment of simultaneous assessment of HIV-1 Nef-mediated down-regulation of cell surface HLA-A and HLA-B molecules
P-40
Takeshi Nishijima
[NCGM/ Kumamoto Univ.]
Is routine ophthalmologic screening useful in care of patients with HIV-1 infection?
P-41
O-3B-28
Daisuke Mizushima
[NCGM/ Kumamoto Univ.]
Prognosis of renal function of Vietnamese HIV-infected patients with mild-to-moderate renal dysfunction on tenofovir
P-42
O-3B-32
Yasuaki Yanagawa
[NCGM/ Kumamoto Univ.]
Long-term Prognosis for HIV Associated Kaposi’s Sarcoma In the Era of cART in Japan
P-43
O-3B-34
Sarah Ameen Almofty
[Kumamoto Univ.]
A TREX-2 component GANP is dispersed from the nuclear envelope during HIV-1 virus entry and associated with integrase in the host cell nucleus
P-44
O-3B-35
Mayuko Shimoda
[Kumamoto Univ.]
GANP that interacts with HIV-1 integrase inherently suppresses retrotransposition
P-45
O-3B-33
Ekram W. Abd El- Wahab
[Kumamoto Univ.]
Specific Recognition of the HIV-1 genomic RNA by the Gag precursor
P-46
Xiaomei T. Kuang
[Simon Fraser Univ., Canada]
Examining HIV-1 Epitope Presentation in the Presence of HDAC inhibitors
 
Home (Japanese)
Home (English)
Center for AIDS Research HP